Posts

Our Correspondence with Ministry of Health & DRAP dated June 11, 2024

  Honorable Health Minister, As-Salaam-Alaikum. I am writing to refer to our previous communication over Facebook and WhatsApp regarding vision impairment and the availability of low-cost   medicine (avastin). I greatly appreciate the concern you showed during our discussion, especially your prompt response within three minutes of my initial call. I understand that you have significant responsibilities overseeing Punjab, the largest province of Pakistan. However, as we discussed, this issue is not a personal matter affecting only me; it impacts a considerable community who suffers from this disease and struggles due to the unavailability of affordable medicine. Today, I contacted my doctor for another dose of avastin, but I was informed that the low-cast medicine is still not available. Could you please take swift action to ensure that this low cost medicine (avastin) or its alternative in the approximately same price is made available to the doctors and hospitals that...

Our Correspondence with Ministry of Health dated May 28, 2024

 #Aims to #End Blindness #EndBlindness Our First letter to the Ministry of Health - Pakistan Dear Honorable Health Minister,   I hope this message finds you well. I am writing to draw your attention to a matter of utmost importance regarding vision loss in our country, particularly concerning the accessibility of Avastin (bevacizumab) for low-income patients in Pakistan. As you may be aware, the recent findings of the third National Survey of Blindness in Pakistan, published in Dawn on September 7, 2022, revealed alarming statistics. Over 9 million individuals in our nation are afflicted with vision impairment, ranging from mild impairment to permanent blindness. Avastin, a vital medication for addressing this issue, has been priced at Rs. 28,800 per 100 mg pack by Roche. To make it more affordable for low-income patients, it has been repackaged into smaller doses suitable for one-time eye injections, priced between Rs. 1,200 to 1,800 per dose. However, in the past eig...